Vestibular Migraine
Conditions
Interventions
1:venlafaxine
2:flunarizine
3:valproic acid
Sponsors
Qianfoshan Hospital of Shandong province
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Eligible participants were male and female outpatients aged 18 years or older with a primary diagnosis of VM based on the criteria.
Exclusion criteria
Exclusion criteria: Additional inclusion criteria that specified patients were as follows: two or more migraine attacks per month or very disabling attacks; nonpharmaceutical treatment couldn't change the attacks. Patients with associated benign paroxysmal positional vertigo, Meniere's disease, chronic discharging ear, past history of ear surgery, profound hearing loss, women who were breast-feeding and patients with major cardiovascular, metabolic, gastrointestinal, neurologic diseases, will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dizziness Handicap Inventory (DHI) scores;the number of vertiginous attacks in the last month;the Vertigo Severity Score (VSS); | — |
Countries
China
Contacts
Public ContactYu Shudong
Qianfoshan Hospital of Shandong province
Outcome results
None listed